REFRACTORY SOLID TUMORS
Clinical trials for REFRACTORY SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY SOLID TUMORS trials appear
Sign up with your email to follow new studies for REFRACTORY SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to boost cancer treatment
Disease control CompletedThis early-phase trial tested whether adding nilotinib (a pill) to paclitaxel (a chemotherapy) is safe and tolerable for people with advanced solid tumors that no longer respond to standard treatments. The study included 47 adults and children aged 12 and older. Researchers aimed…
Matched conditions: REFRACTORY SOLID TUMORS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for kids with tough cancers: experimental combo shows promise
Disease control CompletedThis early-phase study tested a three-drug combination (carfilzomib, cyclophosphamide, and etoposide) in 4 children whose solid tumors or leukemias had come back or didn't respond to standard treatment. The main goal was to find the safest dose and identify side effects. The stud…
Matched conditions: REFRACTORY SOLID TUMORS
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC